Treatment Effectiveness
User reported effectiveness ratings Pregabalin (Lyrica) for various conditions.
Conditions | Major Improvement | Moderate Improvement | Much Worse | No Effect | Worse | Responses |
---|---|---|---|---|---|---|
Fibromyalgia | 10% | 21% | 21% | 31% | 17% | 223 |
Migraine | 2% | 18% | 17% | 48% | 15% | 82 |
Neuropathy | 13% | 35% | 18% | 25% | 10% | 40 |
Peripheral Neuropathy | 21% | 50% | 7% | 21% | 0% | 14 |
Side Effects
User-reported side effects of Pregabalin (Lyrica)
Side Effect | Percent of Reports Pregabalin (Lyrica) |
---|---|
Back Pain | 32% |
Constipation | 38% |
Dry Mouth | 54% |
Bloating | 36% |
Cellcept | 1% |
Cold Sweats | 20% |
Confusion | 40% |
Delirium | 10% |
Difficulty Concentrating or Paying Attention | 55% |
Difficulty Remembering or Forgetfulness | 62% |
Dizziness | 56% |
Double Vision | 23% |
Increased Appetite | 31% |
Lack of Coordination | 43% |
Loss of Balance or Unsteadiness | 50% |
Muscle Twitching | 35% |
Speech Problems | 27% |
Swelling of the Arms, Hands, Feet, Ankles, or Lower Legs | 35% |
Uncontrollable Shaking or Jerking of a Part of the Body | 20% |
Vomiting | 9% |
Weakness | 41% |
Weight Gain | 51% |
Anxiety / Nervousness | 33% |
Tiredness | 61% |
Headache | 41% |
Nausea | 33% |
Gas | 33% |
''high'' or Elevated Mood | 18% |
Outcomes
Below is the degree of change seen after Pregabalin (Lyrica) is higher than average.

Don't see what you're looking for?
Create a study and help us eradicate suffering!
Outcomes Label
Outcomes
of
Below is the change in the listed outcome after
is higher than average.
(Math.abs(a['change']) < Math.abs(b['change'])) ? 1 : -1)" title="Click to put the results with the largest observed change at the top">
Sort by Effect Size
(a['number_of_days'] < b['number_of_days']) ? 1 : -1)" title="Click to put the results with the most supporting data points at the top.">
Sort by Confidence
Pregabalin (Lyrica) Info
Property | Value |
---|---|
Variable Name | Pregabalin (Lyrica) |
Aggregation Method | SUM |
Analysis Performed At | 2020-03-15 |
Duration of Action | 21 days |
Filling Value | 0 |
Minimum Allowed Value | 0 count |
Number of Aggregate Predictors | 0 |
Number of Aggregate Outcomes | 0 |
Number of Measurements | 0 |
Number of Measurements (including those generated by tagged, joined, or child variables) | 0 |
Public | true |
Onset Delay | 30 minutes |
Unit | Count |
User Variables | 1 |
Variable Category | Treatments |
Variable ID | 94897 |